How Hyperbaric Oxygen Therapy Works — The Complete Science

Oxygen is not just what you breathe. At twice normal atmospheric pressure, it dissolves directly into your blood plasma — reaching every tissue in your body that needs repair, including the ones your circulation can no longer fully reach.

 

[IMAGE: how-hbot-works-hyperbaric-oxygen-therapy-mechanism-hero.jpg | Alt: how hyperbaric oxygen therapy works — HBOT mechanism science plasma oxygenation angiogenesis]

 

Hyperbaric Oxygen Therapy (HBOT): A medical therapy in which a person breathes 100% pure oxygen inside a pressurised chamber at 1.5 to 2.4 times normal atmospheric pressure. The increased pressure causes oxygen to dissolve directly into blood plasma — delivering therapeutic concentrations of oxygen to tissues throughout the body, including areas with compromised circulation.

 

Most people have breathed the same air their entire lives without thinking about it.

Air at sea level is approximately 21% oxygen, delivered at one atmosphere of pressure. Your red blood cells pick up what they can carry. The rest — the plasma, the fluid, the tissue between vessels — receives what diffuses across from the blood.

For most purposes, this is enough. But for tissue that is healing, infected, ischaemic, or injured, the oxygen delivered by normal breathing is often insufficient. The wound that will not close. The bone infection that antibiotics cannot clear. The brain that is recovering from stroke or trauma. These conditions share a common biological thread: they require more oxygen than normal circulation can deliver.

HBOT changes this. Not by delivering more air — but by changing the physical conditions under which oxygen is absorbed by the blood and delivered to tissue. The mechanism is based on two physics laws that are as settled as any science in medicine. And the clinical evidence built on that mechanism spans 60 years and thousands of studies.

This page explains both — the physics and the evidence — in plain language. By the end, the mechanism will not be a black box. It will be a logical, inevitable consequence of well-understood science.

 

The Physics Behind HBOT — Two Laws That Explain Everything

HBOT’s mechanism is not pharmacological. It does not work through a drug or a chemical reaction. It works through physics — specifically through two gas laws that govern how oxygen behaves under pressure.

Boyle’s Law — Pressure and Volume

Boyle’s Law states that the volume of a gas is inversely proportional to the pressure applied to it. Double the pressure — halve the volume. This is why a balloon shrinks when squeezed.

In the context of HBOT, Boyle’s Law explains why increased atmospheric pressure inside the chamber makes more oxygen available for absorption. As pressure rises, gas molecules are forced into closer proximity. The concentration of oxygen in the breathing gas increases proportionally with the pressure.

Boyle’s Law is also the mechanism behind HBOT’s effectiveness in arterial gas embolism and decompression sickness — at 2.8 ATA, a gas bubble in an artery physically shrinks to 36% of its original volume, allowing blood flow to resume around it.

Henry’s Law — Dissolved Gas and Pressure

Henry’s Law states that the amount of gas dissolved in a liquid is proportional to the partial pressure of that gas above the liquid. More pressure — more gas dissolves into the liquid.

This is the central mechanism of HBOT’s therapeutic effect. At normal atmospheric pressure (1 ATA), breathing air, your blood plasma carries approximately 0.3 ml of dissolved oxygen per 100 ml of blood. This is approximately 1.5% of what haemoglobin carries — essentially negligible.

At 2.0 ATA, breathing 100% oxygen, plasma oxygen concentration rises to approximately 4.4 ml per 100 ml. At 2.4 ATA — the pressure used in most therapeutic protocols — it reaches approximately 6.0 ml per 100 ml. This is enough to meet the resting metabolic oxygen requirements of tissue without any haemoglobin contribution at all.

Pressure (ATA) Gas Breathed Plasma O₂ (ml/100ml blood) Equivalent to
1.0 ATA Normal air (21% O₂) 0.3 ml Baseline — normal breathing
1.0 ATA 100% oxygen 2.0 ml Standard oxygen therapy — mask or cannula
2.0 ATA 100% oxygen 4.4 ml Standard HBOT — most therapeutic indications
2.4 ATA 100% oxygen 6.0 ml Meets resting tissue O₂ needs via plasma alone
2.8 ATA 100% oxygen 7.2 ml Used for DCS and arterial gas embolism
3.0 ATA 100% oxygen 7.8 ml Maximum standard therapeutic pressure

At 2.4 ATA, blood plasma alone — without haemoglobin — carries enough dissolved oxygen to meet resting tissue requirements. An artery can be blocked. A wound can have compromised circulation. Oxygen still arrives through plasma diffusion. This is what standard oxygen therapy cannot do.

 

documented that the primary mechanism of HBOT is this dramatic increase in plasma-dissolved oxygen — enabling delivery to hypoxic tissues beyond the reach of normal haemoglobin-dependent transport.

 

What HBOT Does Inside the Body — Six Biological Processes

Increased plasma oxygen is the input. But the body responds to that input with a cascade of biological processes — each with documented therapeutic consequences. This is why HBOT works for so many different conditions: the mechanisms it triggers are fundamental to tissue repair, immune function, and cellular health.

Process 1 — Oxygenation of Hypoxic Tissue

The most direct effect. Plasma-dissolved oxygen diffuses into tissue through whatever pathway exists — not just through functioning blood vessels. Chronically hypoxic tissue — in a wound, an infected bone, a post-radiation field — receives oxygen it has been denied.

Every process of healing that has stalled due to oxygen deprivation can now resume. Fibroblasts produce collagen. Immune cells mount their full response. Epithelial cells divide and close the wound. The biology restarts where it had stopped.

Process 2 — Angiogenesis: Building New Blood Vessels

This is HBOT’s most important long-term mechanism. The hyperoxic-hypoxic cycle — high oxygen during sessions, relative hypoxia between sessions — creates the precise signalling environment that stimulates new blood vessel growth.

HBOT stimulates vascular endothelial growth factor (VEGF) and mobilises vasculogenic stem cells from bone marrow — documented by . Over a course of 20 to 40 sessions, new capillary networks form in previously hypovascular tissue — creating a lasting improvement in oxygen supply that persists long after the treatment course ends.

For radiation injury, diabetic wounds, and chronic ischaemia — where the fundamental problem is inadequate blood supply — angiogenesis is the mechanism that explains why HBOT produces durable improvements rather than temporary relief.

Process 3 — Stem Cell Mobilisation

A landmark study by  demonstrated that HBOT produces an 8-fold increase in circulating stem cells — mobilised from bone marrow into the bloodstream. These cells — CD34+ progenitor cells — travel to sites of injury and support tissue regeneration.

For wounds, brain injuries, and ischaemic tissue, this systemic mobilisation of repair cells provides resources beyond what local tissue can generate. The body recruits its own repair capacity from a source the wound cannot access on its own.

Process 4 — Anti-Infective Effects

HBOT creates a tissue environment that is directly hostile to anaerobic bacteria — organisms whose metabolism requires the absence of oxygen. At 2.0 to 2.5 ATA, tissue oxygen tension rises to levels that are directly bactericidal for obligate anaerobes.

For aerobic bacteria, HBOT potentiates both antibiotic efficacy and leukocyte killing. Aminoglycoside antibiotics require oxygen for bacterial uptake — their killing mechanism is impaired in hypoxic tissue. Leukocytes require an oxygen gradient above 30 mmHg for the oxidative burst that kills bacteria. HBOT restores both.

confirmed that HBOT enhances both antibiotic efficacy and immune killing capacity — making it the specific tool for infections in hypoxic tissue environments.

Process 5 — Reduction of Oedema and Inflammation

HBOT at therapeutic pressure causes mild vasoconstriction in non-ischaemic tissue — reducing tissue oedema without compromising oxygen delivery (because plasma oxygenation compensates for reduced flow).  documented that HBOT reduces neutrophil adhesion to damaged endothelium — one of the primary drivers of inflammatory tissue damage — creating a controlled oxygenation environment that limits rather than amplifies inflammatory cascades.

For burns, crush injuries, reperfusion injury, and post-radiation oedema, this anti-inflammatory mechanism is clinically significant.

Process 6 — Mitochondrial Protection and Support

Carbon monoxide — the most studied mitochondrial toxin — binds to cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain, disrupting cellular energy production. HBOT at therapeutic pressure displaces CO from cytochrome c oxidase and restores ATP synthesis.  documented that HBOT protects mitochondrial membrane properties under conditions of neurological injury — preserving the cellular energy infrastructure that brain recovery depends on.

 

[IMAGE: hbot-six-biological-processes-mechanism-diagram.jpg | Alt: HBOT six biological processes — angiogenesis stem cells anti-infective oedema reduction mitochondria]

 

Where the Evidence Is Strongest — The 14 FDA-Recognised Indications

The U.S. Food and Drug Administration and the Undersea and Hyperbaric Medical Society (UHMS) have formally recognised HBOT for 14 medical indications. These are conditions where the clinical evidence base is strong enough for regulatory approval — representing six decades of controlled research across hundreds of thousands of patients.

# FDA-Recognised Indication Primary HBOT Mechanism
01 Diabetic wounds and non-healing ulcers Plasma oxygenation + angiogenesis + anti-infective
02 Decompression sickness Boyle’s Law bubble compression + plasma oxygenation
03 Carbon monoxide poisoning CO elimination + mitochondrial protection + neuroinflammation reduction
04 Gas gangrene (clostridial myonecrosis) Direct bactericidal + toxin suppression + tissue margin preservation
05 Radiation injury (late tissue effects) Angiogenesis in hypovascular tissue + fibroblast reactivation
06 Crush injuries and compartment syndrome Plasma oxygenation + reperfusion injury modulation
07 Refractory osteomyelitis Antibiotic potentiation + leukocyte killing restoration + biofilm disruption
08 Necrotising soft tissue infections Direct anaerobic bactericidal + toxin suppression + leukocyte potentiation
09 Acute arterial insufficiency Plasma diffusion oxygenation without blood flow + oedema reduction
10 Arterial gas embolism Boyle’s Law bubble compression + gas reabsorption acceleration
11 Severe anaemia (no transfusion) Plasma oxygenation replaces haemoglobin oxygen transport
12 Thermal burns Zone of stasis preservation + anti-inflammatory + angiogenesis
13 Intracranial abscess Antibiotic potentiation + neurological tissue oxygenation
14 Compromised skin grafts and flaps Graft bed oxygenation + angiogenesis + anti-infective

HBOTLAB’s Knowledge Centre covers every one of these 14 indications in depth — with the full evidence base, clinical protocols, and India-specific context. Explore the HBOT conditions section to find the indication most relevant to you.

 

What an HBOT Session Actually Looks Like

Understanding the mechanism is one thing. Knowing what to expect when you walk into a hyperbaric facility is another. Here is the complete picture of a standard HBOT session — from arrival to the biological effects that continue after you leave.

Before the Session

  • A medical assessment is completed before your first session — reviewing your medical history, current medications, and any contraindications
  • No smoking for at least 4 hours before a session — nicotine causes vasoconstriction that reduces HBOT’s effectiveness
  • No alcohol or recreational drugs — both interfere with oxygen metabolism
  • Comfortable cotton clothing is provided — synthetic fibres are not permitted in the chamber due to fire safety protocols
  • Jewellery, watches, and electronic devices are removed before entering

 

Inside the Chamber

You lie or sit comfortably in the hyperbaric chamber. As pressurisation begins, you will notice a sensation similar to descending in an aeroplane — mild ear pressure as the pressure equalises. Staff guide you through ear equalisation techniques (swallowing, yawning) if needed.

The chamber reaches its target pressure — typically 2.0 to 2.4 ATA — over approximately 10 to 15 minutes. Once at pressure, you breathe 100% pure oxygen through a hood, mask, or the chamber atmosphere itself, depending on the chamber type.

A standard treatment session lasts 90 minutes at pressure. You can read, rest, or sleep during the session. Staff monitor you throughout via intercom and window.

Depressurisation at the end of the session takes approximately 10 to 15 minutes — slow enough to allow gas to leave the body safely.

After the Session

Most patients feel mildly tired after the first few sessions — a normal response as the body adjusts to the increased oxygen load. Many report improved energy and clarity after the first week of treatment.

The biological processes triggered by HBOT — angiogenesis, stem cell activity, collagen synthesis — continue between sessions and for weeks after the treatment course ends. The benefits accumulate over the course of treatment, not just during individual sessions.

Session Duration vs Benefit HBOT benefit is cumulative and dose-dependent. A single session produces immediate oxygenation of hypoxic tissue. Lasting benefit — angiogenesis, stem cell repair, collagen synthesis — requires a full course of sessions. Most protocols run 20 to 40 sessions for therapeutic indications. Wellness protocols may be shorter.

Monoplace vs Multiplace Chambers — What Is the Difference

Feature Monoplace Chamber Multiplace Chamber
Capacity One patient at a time Multiple patients simultaneously — 2 to 20+
Pressurisation medium Pure oxygen — the entire chamber fills with O₂ Compressed air — patients breathe O₂ through mask or hood
Clinical monitoring Through porthole — limited access to patient Attendant inside chamber — full ICU-level care possible
Typical use Outpatient wellness and elective indications Acute, critical, and complex indications; ICU patients
Fire safety Higher risk — pure O₂ environment requires strict protocols Lower risk — chamber atmosphere is air, not O₂
Cost Lower capital cost Higher capital cost — larger infrastructure
Availability in India More common — smaller facilities Available at major hospital-based hyperbaric units

Both chamber types deliver equivalent therapeutic outcomes when operated at the correct pressure and duration. The choice of chamber is a facility decision based on patient acuity, throughput, and clinical needs — not a determinant of treatment quality.

 

Is HBOT Safe — The Honest Answer

HBOT has an established safety record across more than six decades of clinical use and millions of sessions globally. Serious adverse events are rare. The most common side effects are mild and temporary.

Common — Mild and Temporary

  • Ear barotrauma — pressure discomfort during pressurisation, equivalent to aeroplane descent. Managed with equalisation techniques. Resolves when pressure equalises.
  • Sinus squeeze — pressure discomfort in the sinuses. More common in patients with active congestion. Managed by decongestant use and equalisation.
  • Mild fatigue after early sessions — normal physiological adjustment. Typically resolves after the first week of treatment.
  • Temporary myopia — some patients experience mild visual blurring during treatment courses, especially longer ones. Fully reversible after treatment ends.

Rare — Managed With Protocol

  • Oxygen toxicity — seizures from excessive oxygen exposure. Extremely rare at therapeutic pressures (2.0–2.4 ATA). Prevented by air breaks built into standard protocols and by patient selection screening.
  • Middle ear barotrauma — more severe ear pressure injury. Prevented by proper equalisation guidance and slow pressurisation rates.

 

Contraindications — Who Should Not Receive HBOT

  • Untreated pneumothorax — absolute contraindication. Must be drained before HBOT.
  • Certain chemotherapy agents — bleomycin, doxorubicin, cisplatin — specific interactions require physician review.
  • Uncontrolled high fever — increases seizure risk with oxygen.
  • Severe claustrophobia — manageable in many cases with anxiolytic medication; severe cases may preclude treatment.

 

For a complete guide to HBOT safety, side effects, and contraindications, read our detailed HBOT safety and risks guide.

 

HBOT in India — Access, Cost, and What to Expect

HBOT is available across India at both hospital-based hyperbaric units and dedicated wellness centres. India’s HBOT infrastructure has grown significantly in the past decade — from isolated hospital units to an emerging organised wellness network.

Where HBOT Is Available in India

 

Cost of HBOT in India

Session costs in Indian metros typically range from Rs. 3,500 to Rs. 10,000 per session depending on facility type, city, chamber type, and indication. A standard course of 20 sessions costs approximately Rs. 70,000 to Rs. 1,50,000. Longer courses for complex indications range from Rs. 1,50,000 to Rs. 3,00,000.

For insurance and coverage guidance, see our HBOT insurance in India guide.

 

Frequently Asked Questions

Is HBOT the same as oxygen therapy at a hospital?

No. Hospital supplemental oxygen is delivered at normal atmospheric pressure (1 ATA) — either through a mask or nasal cannula. It increases the oxygen content of the air you breathe but does not change the physical conditions of absorption. Plasma-dissolved oxygen increases minimally. HBOT delivers oxygen at 2.0 to 2.4 times normal atmospheric pressure — creating a fundamentally different absorption environment where oxygen dissolves directly into plasma at therapeutic concentrations. The pressure is what makes HBOT work. Without it, you are simply breathing enriched air.

How many HBOT sessions do I need?

Session count depends entirely on the indication and the patient’s clinical response. General wellness and performance: 10 to 20 sessions. Sports injury rehabilitation: 10 to 20 sessions. Wound healing: 20 to 40 sessions. Neurological recovery: 40 or more sessions. Radiation injury: 30 to 60 sessions. A qualified HBOT physician should assess your specific situation before recommending a protocol. Response is assessed at regular intervals throughout treatment.

Does HBOT hurt?

No. The most common sensation is mild ear pressure during pressurisation — identical to what you feel descending in an aeroplane. This is easily managed with swallowing or yawning and resolves within seconds. Inside the chamber, the experience is quiet and comfortable. Most patients read or rest during sessions.

Can children receive HBOT?

Yes. HBOT has been studied and used in paediatric populations — including children with autism spectrum disorder, cerebral palsy, and brain injuries. Paediatric protocols use the same pressure parameters as adult protocols. A parent or guardian can accompany younger children inside a multiplace chamber. The safety profile in paediatric populations is well-established.

How quickly will I see results?

Some patients notice improved energy and reduced inflammation within the first 5 to 10 sessions. For wound healing, measurable wound size reduction typically becomes apparent after 15 to 20 sessions. Neurological improvements often emerge progressively over a longer course. The biological processes triggered by HBOT — angiogenesis, collagen synthesis, stem cell activity — continue building for weeks after the course ends. Full assessment of benefit is typically made 4 to 8 weeks after completing a course.

Is HBOT effective for conditions not on the FDA approved list?

A growing body of peer-reviewed research supports HBOT across conditions beyond the 14 FDA-recognised indications — including long COVID, traumatic brain injury in sports contexts, Alzheimer’s disease, longevity and anti-aging, and mental health conditions including depression and PTSD. This research is active and growing. HBOTLAB’s Knowledge Centre covers the evidence base for emerging applications honestly — distinguishing between what established evidence supports and what is still being studied.

 

Explore the HBOTLAB Knowledge Centre

Every article in the HBOTLAB Knowledge Centre is written to the same standard as this page — research-cited, plainly explained, and honest about what evidence supports and what it does not. Find the topic most relevant to you.

 

Conditions and Indications

Costs, Access, and Safety

 

What You Now Know

Hyperbaric oxygen therapy is not magic. It is physics — applied precisely, with documented biological consequences that six decades of research have mapped in detail.

Henry’s Law explains why plasma-dissolved oxygen increases with pressure. Boyle’s Law explains why gas bubbles shrink. The documented biological processes — angiogenesis, stem cell mobilisation, antibiotic potentiation, mitochondrial protection — explain why this single intervention produces measurable outcomes across 14 distinct FDA-recognised indications.

The question for most Indian patients is not whether HBOT works. The question is whether it is relevant to their specific situation — and whether they can access it.

The Knowledge Centre exists to answer the first question honestly. For the second — HBOTLAB’s growing network is the answer to the second.